Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Glucagon
Drug ID BADD_D01025
Description Glucagon is a 29 amino acid hormone used as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519] Glucagon raises blood sugar through activation of hepatic glucagon receptors, stimulating glycogenolysis and the release of glucose.[L7640,L7643] Glucagon was granted FDA approval on 14 November 1960.[L7631]
Indications and Usage Glucagon is indicated as a diagnostic aid in radiologic exams to temporarily inhibit the movement of the gastrointestinal tract and to treat severe hypoglycemia.[L7634,L7637,L7640,L7643,L8519]
Marketing Status approved
ATC Code H04AA01
DrugBank ID DB00040
KEGG ID D00116; D02118
MeSH ID D005934
PubChem ID 16132283
TTD Drug ID Not Available
NDC Product Code 0002-7529; 43742-0734; 63323-594; 51662-1498; 0002-6145; 63323-582; 63323-593; 63323-596; 0002-8031; 66558-0195; 41524-0005; 0548-5850; 55463-0009; 63083-1555; 50090-6550
UNII 76LA80IG2G
Synonyms Glucagon | Proglucagon (33-61) | HG-Factor | HG Factor | Glukagon | Glucagon (1-29) | Hyperglycemic-Glycogenolytic Factor | Hyperglycemic Glycogenolytic Factor
Chemical Information
Molecular Formula C153H225N43O49S
CAS Registry Number 9007-92-5
SMILES CC(C)CC(C(=O)NC(CCSC)C(=O)NC(CC(=O)N)C(=O)NC(C(C)O)C(=O)O)NC(=O)C(CC1=CNC2=CC=CC =C21)NC(=O)C(CCC(=O)N)NC(=O)C(C(C)C)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(CC(=O)O)NC(=O)C (CCC(=O)N)NC(=O)C(C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CO)NC(=O)C(CC( =O)O)NC(=O)C(CC(C)C)NC(=O)C(CC4=CC=C(C=C4)O)NC(=O)C(CCCCN)NC(=O)C(CO)NC(=O)C(CC5 =CC=C(C=C5)O)NC(=O)C(CC(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC6=CC=CC=C6)NC(=O )C(C(C)O)NC(=O)CNC(=O)C(CCC(=O)N)NC(=O)C(CO)NC(=O)C(CC7=CN=CN7)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Blood pressure increased13.14.03.005--Not Available
Drug interaction08.06.03.001--Not Available
Heart rate increased13.14.04.002--Not Available
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypoglycaemia14.06.03.001; 05.06.03.001--
Hypoglycaemic coma17.02.09.005; 14.06.03.004; 05.06.03.004--Not Available
Hypotension24.06.03.002--
Nausea07.01.07.001--
Tachycardia02.03.02.007--Not Available
Vomiting07.01.07.003--
Toxicity to various agents12.03.01.046--Not Available
The 1th Page    1    Total 1 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene